TOBRAMYCIN

23590 reported adverse events

Drug classes: Aminoglycoside Antibacterial [EPC]

These side effects are most commonly reported by patients taking TOBRAMYCIN:

# Side effect Count
0 OFF LABEL USE 2021
1 DEATH 1706
2 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1580
3 PNEUMONIA 1529
4 DYSPNOEA 1427
5 COUGH 1300
6 CYSTIC FIBROSIS 1283
7 HOSPITALISATION 1053
8 CONDITION AGGRAVATED 975
9 DRUG INEFFECTIVE 875
See all common reactions for TOBRAMYCIN

TOBRAMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1580 0.2900
1 CYSTIC FIBROSIS LUNG 33 0.2578
2 CYSTIC FIBROSIS 1283 0.2315
3 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 161 0.1803
4 CYSTIC FIBROSIS RELATED DIABETES 26 0.1781
5 CHOROIDITIS 64 0.1711
6 INFECTIVE KERATITIS 12 0.1690
7 INFECTIVE EXACERBATION OF BRONCHIECTASIS 46 0.1498
8 PSEUDOMONAS BRONCHITIS 10 0.1449
9 ACQUIRED FACTOR V DEFICIENCY 14 0.1273
See all enriched reactions for TOBRAMYCIN